Patents by Inventor Kevin Hodggetts

Kevin Hodggetts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
    Publication number: 20050176721
    Abstract: Diarylpyrazine, diarylpyridine, and diarylpyrimidine compounds that act as selective modulators of CRF 1 receptors are provided. These compounds are useful in the treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided. Compounds of Formula I are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.
    Type: Application
    Filed: April 4, 2005
    Publication date: August 11, 2005
    Inventors: Jianhua Huang, Kevin Hodggetts, Dario Doller, Ping Ge, Yasuchika Yamaguchi
  • 2,5-diarypyrimidine compounds
    Patent number: 6887875
    Abstract: Diarylpyrimidine compounds of Formula I are provided, wherein.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: May 3, 2005
    Assignee: Neurogen Corporation
    Inventors: Jianhua Huang, Kevin Hodggetts, Dario Doller, Ping Ge, Yasuchika Yamaguchi
  • 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines
    Publication number: 20030119844
    Abstract: Diarylpyrazine, diarylpyridine, and diarylpyrimidine compounds that act as selective modulators of CRF 1 receptors are provided. These compounds are useful in the treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided.
    Type: Application
    Filed: May 22, 2002
    Publication date: June 26, 2003
    Applicant: Neurogen Corporation
    Inventors: Jianhua Huang, Kevin Hodggetts, Dario Doller, Ping Ge, Yasuchika Yamaguchi